Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Bristol-Myers Squibb (BMS) and Agenus, a Lexington, Massachusetts-based clinical-stage immuno-oncology company, have entered into a $1.56-billion agreement for Agenus’ bispecific antibody program. Under the agreement, BMS will be granted a global...

The US Food and Drug Administration (FDA) has issued a final guidance on pharmaceutical product lifecycle management in line with a recent guideline from the International Conference on Harmonization of Technical Requirements for Pharmaceuticals...

Biogen and Capsigen, a Vancouver, Washington-based gene-therapy company, have entered into a strategic research collaboration to develop gene therapies for central nervous system (CNS) and neuromuscular disorders, in a deal worth up to $1.3 billion...

Roivant Sciences, a New York-based bio/pharmaceutical and healthcare technology company, and Montes Archimedes Acquisition Corp. (MAAC), a special purpose acquisition company (SPAC) sponsored by Patient Square Capital, have formed a merger...

Teva Pharmaceutical Industries, Eli Lilly and Company, and Viatris, the new company formed from the combination of Mylan and Upjohn, Pfizer’s off-patent branded and generic established medicines business, have outlined environmental, social, and...